The bactericidal activity of M14659 against Escherichia coli in low-iron environments was investigated and compared with that of ceftriaxone and ceftazidime. The bactericidal activity of M14659 against E. coi in Mueller-Hinton broth was enhanced 30-to 20,000-fold by addition of transferrin, which is an iron-binding protein, whereas the activity of ceftriaxone or ceftazidime was much less strongly affected. This enhancement by transferrin was completely inhibited by saturating the iron-binding capacity of transferrin with FeCl3.
antibacterial activity in vitro against other gram-negative bacteria in the low-iron environments. These findings indicate that M14659 may be actively taken up with Fe3' into bacterial cells, probably through the iron transport systems under conditions of low iron and, thus, kills bacteria effectively. Fig. 1 ) is a novel antipseudomonal cephalosporin which has a balanced spectrum of activity and more potent in vivo activities than ceftazidime against gram-positive and gram-negative bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa (14) . We have also reported that M14659 shows high affinities for penicillin-binding proteins 1A, 1B, and 3 of Escherichia coli and P. aeruginosa (14) . This finding indicates that the bactericidal activity of M14659 against these bacteria may be essentially potent and that M14659 is expected to kill the bacteria effectively even in a living body. In a vertebrate body, however, iron-binding proteins such as transferrin and lactoferrin exist and make a low-iron environment, restricting iron available for bacterial growth by binding free iron in the body (1, 3, 5, 8, 17) . In addition to such a normal state of a body, a host responds to bacterial infections by reducing levels of iron binding to plasma transferrin. This iron sequestration response, called the hypoferremic response, is an important defense mechanism whereby the host attempts to limit the availability of essential iron to the bacteria (6, 9, 10, 12, 13, 20) . Thus, since a vertebrate body appears to protect itself from bacterial invasion by making a low-iron environment that restricts the iron available to bacteria, it was thought to be desirable to examine the bactericidal activity of an antibiotic in low-iron environments when estimating its killing activity in vivo. In this study, the bactericidal activity of M14659 against E. coli in low-iron environments, which were made by adding iron-binding compounds such as transferrin (Tf), lactoferrin (Lt), and a,a'-dipyridyl (Dp) to Mueller-Hinton broth (MHB), was compared with that of ceftriaxone or ceftazidime, and the mechanism of its bactericidal action in these environments was also investigated. (525 nCi/ml) after filtration with an MPS-3 device, and 10.2 is the iron content in MHB, determined with an atomic absorption spectrophotometer.
M14659 (
Bactericidal activity in ID-MHB. Lf was added to MHB at a concentration of 1 mg/ml, and the mixture was warmed at 37°C for 24 h. Lf was then removed from the MHB with an MPS-3 device, and the filtrate was used as an iron-deficient MHB (ID-MHB; Fe3+ concentration, <2 nM). Bacteria cultured overnight at 37°C were washed with 200 ml of sterilized saline by centrifugation at 4,000 x g for 10 min and suspended in an appropriate volume of the same saline. These bacteria were added to the ID-MHB containing M14659 (1/2 MIC) and FeCl3 (0 to 10 ,uM) to give a final inoculum of 10' CFU/ml (total volume, 1 ml). Portions of 0.1 ml were removed from the solutions after 0, 2, and 4 h of incubation. The number of viable cells was determined by the pour plate technique. Production of enterochelin by the bacteria in the respective broths was also detected after 6 h of incubation at 37°C. The water used in this experiment was distilled in a Barnstead Glass Still (The Barnstead Co., Boston, Mass.) and deionized with a NANO pure II (The Barnstead Co.).
RESULTS
Effect of iron-binding compounds on the bactericidal activity of M14659. The bactericidal activity of M14659 at 1/2 MIC against E. coli NIHJ JC-2 was scarcely affected in the presence of 0.1 or 0.3 mg of Tf per ml, but was enhanced by the addition of Tf at 1 mg/ml (Fig. 2) . Since it has been reported that Tf exists at 2 to 3 mg/ml in human serum (17) , 1 mg/ml was thought to be quite reasonable as a concentration of Tf and was therefore used in the following experiments. The bactericidal activity of M14659 at 1/2 and 1/4 MIC in the presence of Tf was enhanced 30-and 50-fold after 2 h of incubation and 20,000-and 6,000-fold after 4 h, respectively (Fig. 3) . On the other hand, bactericidal activities of ceftriaxone and ceftazidime at 1/2 and 1/4 MIC 2 h after incubation were not affected by the addition of Tf at 1 mg/ml. After 4 h of incubation, their bactericidal activities at 1/2 and 1/4 MIC were enhanced to some extent, but the degree of their enhancement was 1/20 to 1/1,500 of that of M14659 (Fig. 3) . Lf (1 mg/ml) and Dp (200 ,uM), which are both iron-binding compounds, enhanced the bactericidal activity of M14659 at 1/4 MIC to the same extent as Tf at 1 mg/ml did (Fig. 4) .
The enhancement by Tf of the bactericidal activity of M14659 against E. coli NIHJ JC-2 was completely inhibited by the addition of FeCl3 at a concentration capable of saturating the iron-binding capacity of Tf, whereas it was scarcely inhibited by the addition of the same amount of CaCl2, MgCI2, ZnCl2, or CuCl2 (Fig. 5) .
In the presence of Tf, Lf, and Dp, E. coli NIHJ JC-2 at 108 CFU/ml produced enterochelin, which indicates derepression of the bacterial iron transport systems (2, 4 (Fig. 6) .
DNP (1 mM), which is an uncoupler of oxidative phosphorylation and is thought to facilitate proton movement across the cytoplasmic membrane and thus to dissipate the energized membrane state (7) , completely inhibited the uptake of [14C]M14659 into E. coli NIHJ JC-2 cells in the presence of Tf (Fig. 6 ).
Chelating activity of M14659 to Fe3. The color of the solution of M14659 changed to blue-green when FeCl3 was added, and the optical absorption at 500 to 700 nm increased U.7 according to the color change (Fig. 7) well known much lower than that of desferrioxamine B (7 and 10% at 10 (s), such as and 100 ,ug/ml, respectively). Although M14659 has a che-3), the color lating activity to Fe3" (Fig. 7) , it turned out that the chelating seemed to activity of M14659 was not so strong as to be able to remove
Fe3" from Fe3"-binding Tf.
Removal of Time course of binding between iron-binding proteins and is shown in
Fe3+. The gram-negative bacteria determined by agar dilution on Mueller-Hinton agar (MHA) containing Dp at 200 ,uM are shown in Table 2 . MICs of M14659, ceftriaxone, and ceftazidime against gram-positive bacteria such as Staphylococcus aureus, S. epidermidis, and Enterococcusfaecalis were scarcely affected by the addition of Dp. Against gramnegative bacteria such as Klebsiella pneumoniae, Citrobacterfreundii, Ehterobacter cloacae, Serratia marcescens, Proteus vulgaris, and P. aeruginosa, MICs of M14659 on MHA supplemented with Dp ranged from .0.006 to 0.10 ,ug/ ml and were 2-to 26-fold lower than those on MHA, which ranged from 0.012 to 0.78 ,ug/ml, whereas MICs of ceftriaxone and ceftazidime, as well as those against gram-positive bacteria, were scarcely affected.
DISCUSSION
The bactericidal activity of M14659 against E. coli was remarkably enhanced in the presence of Tf, Lf, or Dp after 2 and 4 h of incubation, In contrast, the activity of ceftriaxone or ceftazidime was much less strongly affected by the addition of Tf. Since the enhancement of the bactericidal activity of M14659 by Tf disappeared on addition of Fe3" at a concentration capable of saturating the iron-binding capacity of Tf, and since it has been reported that Tf inhibits bacteria by regulating the iron available for their growth, the enhancement by Tf seemed to have been attributable to sequestration of free Fe3" available to the bacteria. In the M14659 was markedly taken up into E. coli cells in the presence of Tf, and its uptake was cotnpletely inhibited by the addition of an uncoupler of oxidative phosphorylation, DNP. In addition to these findings, considering that the uptake of siderophore-iron complexes dependent on the TonB function by E. coli (4) is inhibited by DNP (16), which is thought to facilitate proton movement across the cytoplasmic membrane and thus to dissipate the energized membrane state (7), M14659 may be actively taken up into the bacterial cells through their iron transport systems which are derepressed by sequestering free Fe3" from the bacteria.
Bacterial siderophores such as enterochelin and aerobac- (Table 1) , M14659 had chelating activity for Fe3" (Fig. 7) , and a small amount of free Fe3", which M14659 seems to be able to utilize for chelation, existed in MHB even 4 h after the addition of Tf or Lf. Accordingly, if a small amount of free iron is necessary for the uptake of M14659 into bacterial cells, M14659 will be actively taken up into the bacterial cells; thus, it will be able to kill the bacteria effectively only in the low-iron environment where the bacterial iron transport systems are derepressed and a small amount of Fe3" for chelation of M14659 exists. It has been reported that the bacterial iron transport systems can be derepressed in an environment deficient in iron to a level of <2.0 ,uM (11) . If 1 mol of M14659 chelates 1 mol of iron, the iron concentration necessary for the chelation of M14659 is thought to be at least 40 nM, because about 40 pmol of M14659 per 108 CFU of bacteria in 1 ml of MHB was taken up into the bacterial cells after 4 h of incubation (Fig. 6 ). Fe3" in MHB could be removed to a level of <2 nM, which is thought to be too low for chelation of M14659, by removing Lf from the broth that had been incubated with Lf at 37°C for 24 h. The bactericidal activity of M14659 was scarcely augmented in this ID-MHB, as was also true for ID-MHB supplemented with Fe3" at 10 ,uM, in which E. coli did not derepress the iron transport systems, whereas the bactericidal activity was markedly enhanced by the addition of Fe3" at 0.1 and 1.0 ,u.M. Thus, both a small amount of free Fe3+ and derepression of the bacterial iron transport systems seem necessary for augmentation of the bactericidal activity of M14659. Our findings suggest that M14659 may be actively taken up with Fe3" into E. coli cells, probably through their iron transport systems, and then kills bacteria effectively in low-iron environments. It has been reported that bacteria other than E. coli also can derepress the iron transport systems in low-iron environments (15) . Therefore, the antibacterial activity of M14659 in vitro against various gram-positive and gramnegative bacteria on a low-iron MHA, which was made by addition of Dp to MHA, was examined in comparison with the antibacterial activity of ceftriaxone or ceftazidime. In vitro antibacterial activities of M14659, ceftriaxone, and ceftazidime against gram-positive bacteria were scarcely affected by addition of Dp to MHA. Against gram-negative bacteria the antibacterial activity of M14659 was enhanced 2-to 26-fold in the low-iron agar, whereas the activities of ceftriaxone and ceftazidime were scarcely affected. This finding suggests that M14659 may be actively taken up into various gram-negative bacterial cells, probably through their iron transport systems, which are derepressed in the lowiron environment, and then kills the bacteria effectively. Free iron sufficient for the chelation of M14659 seems to exist at infection sites in mice from hemolysis or release of iron from Tf (17, 19) . M14659 chelates free iron and seems to be actively taken up into bacterial cells, probably through their iron transport systems. Thus, the excellent in vivo activity of M14659 in mice which we have reported (14) may be partly attributable to this characteristic entry into bacterial cells in low-iron environments. If the phenomenon is also borne out for humans, M14659 should show good therapeutic activity against various infections.
